Stock data
Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (BOLT) reported revenue of US$7.70M and net income of -US$33.38M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$7.70M | — | -US$36.11M | -US$33.38M | — |
| 2024 | US$7.69M | — | -US$73.05M | -US$63.12M | — |
| 2023 | US$7.88M | — | -US$76.20M | -US$69.20M | — |
| 2022 | US$5.73M | — | -US$90.32M | -US$88.10M | — |
| 2021 | US$1.26M | — | -US$92.79M | -US$98.59M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.01M | -US$7.72M | — |
| 2026-03-31 | US$0.03M | -US$7.24M | — |
| 2025-12-31 | US$2.50M | -US$6.63M | — |
| 2025-09-30 | US$2.17M | -US$7.14M | — |
| 2025-06-30 | US$1.80M | -US$8.56M | — |
| 2025-03-31 | US$1.22M | -US$11.04M | — |
| 2024-12-31 | US$0.00M | -US$15.94M | — |
| 2024-09-30 | US$1.14M | -US$15.18M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.